Skip to main content
SpringerLink
Log in

Cannabis

  • Chapter
Suchtmittel in der AINS

  • 1500 Accesses

Zusammenfassung

In Europa war Hanf lange als Kulturpflanze zur Gewinnung von Fasern bekannt, ehe im 19. Jahrhundert die Rauschwirkung bestimmter Sorten bekannt wurde. Heute ist Cannabis das am weitesten verbreitete illegale Rauschmittel in Deutschland. Laut Jahresbericht des Bundesgesundheitsministeriums fur das Jahr 2004 haben 32% der 12- bis 25-Jährigen schon einmal illegale Drogen probiert. 24% der Jugendlichen haben ausschließlich Cannabis konsumiert. Ein wichtiger Kofaktor für den Konsum von Cannabis sind Alkohol und Nikotin. Jugendliche, die rauchen und Erfahrung mit einem Alkoholrausch haben, nehmen laut des Berichts deutlich häufiger Cannabis ein als Jugendliche ohne diese Erfahrungen. Auch gilt Cannabis weiterhin als Einstiegsdroge zu den sogenannten harten Drogen wie Kokain und Heroin (BZGA 2004).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arseneault L, Cannon M, Poulton BR, Caspi A: Cannabis use in adolescence and risk for adult psychosis. BMJ 2002; 1212–1213

    Google Scholar 

  • Ashton CH: Adverse effects of cannabis and cannabinoids. BJA 1999; 83: 637–649

    CAS  PubMed  Google Scholar 

  • Beal JA, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B: Dronabinol as treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symp Manag 1995; 10: 89–97

    Article  CAS  Google Scholar 

  • Bell GL, Lau K: Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995; 42: 261–281

    CAS  PubMed  Google Scholar 

  • Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ. Lack of analgesie efficacy of oral δ9-tetrahydrocannbinol i postoperative pain. Anaesthesist 2006, 55: 9391–400

    Google Scholar 

  • BZG (Bundeszentrale für gesundheitliche Aufklärung). Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2004 — Eine Wiederholungsbefragung der Bundeszentrale für gesundheitliche Aufklärung. 2004; BZGA, Köln, www.bzga.de/studien

    Google Scholar 

  • Chabrol H, Fredaigue N, Callahan S: Epidemiological study of cannabis abuse and dependence in 256 adolescents. Encephale 2000; 26: 47–49

    CAS  PubMed  Google Scholar 

  • Chait LD, Perry JL: Acute and residual effects of alcohol and marijuana, alone, and in combination, on mood and performance. Psychopharmacology 1994; 115: 340–349

    Article  CAS  PubMed  Google Scholar 

  • Clifford DB: Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 1983; 13: 669–671

    Article  CAS  PubMed  Google Scholar 

  • Compton DR, Dewey WL, Martin BR: Cannabis dependence and tolerance production. Adv Alcohol Subst Abuse 1990; 9: 128–147

    Google Scholar 

  • Consroe P, Musty R, Tillery W, Pertwee RG: The perceived effects of cannabis smoking in patients with multiple sclerosis. Proceedings of the International Cannabinoid Research Society 1996; 7

    Google Scholar 

  • Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R: Chronic administration of cannabinol to healthy volunteers and epileptic patients. Pharmacol 1980; 21: 175–185

    Article  CAS  Google Scholar 

  • Darling MR, Arendorf TM: Review of the effect of cannabis smoking on oral health. Int Dent J 1992; 42: 19–22

    CAS  PubMed  Google Scholar 

  • Degenhardt L, Hall W, Lynskey M: Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2001; 96:1603–1614

    Article  CAS  PubMed  Google Scholar 

  • Dougherty DM, Cherek DR, Roach JD: The effects of smoked marijuana on progressive-interval schedule performance in humans. J Exp Anal Behav 1994; 62: 73–87

    Article  CAS  PubMed  Google Scholar 

  • Drewe J: Erwunschte und unerwunschte Wirkungen des Cannabiskonsums. Ther Umschau 2003; 60: 313–316

    Article  CAS  Google Scholar 

  • Dunn M, Davis R: The perceived effects of marijuana on spinal cord injured males. Paraplegia 1974; 12: 175

    CAS  PubMed  Google Scholar 

  • Fisher BAC, Ghuran A, Vadamalai V, Antonios TF: Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J 2005; 22: 679–680

    Article  CAS  PubMed  Google Scholar 

  • Ghuran A, Nolan J: Recreational Drug misuse: issues for the cardiologist. Heart 2000; 83: 627–633

    Article  CAS  PubMed  Google Scholar 

  • Green K, Wynn H, Bowman KA: A comparison of topical cannabinoids on intraocular pressure. Exp Eye Res 1978; 27: 239–246

    Article  CAS  PubMed  Google Scholar 

  • Grufferman S, Schwartz AG, Ruymann FB, Maurer HM: Parents use of cocain and marijuana and increased risk for rhabdomyosarkoma in their children. Cancer, Causes & Control 1993; 4: 217–224

    CAS  Google Scholar 

  • Hall W, Solowij N: Adverse effects of cannabis. Lancet 1998; 352: 1611–1616

    Article  CAS  PubMed  Google Scholar 

  • Haney M, Ward AS, Comer SD, Foltin RW, Fischmann MW: Abstinence symptom following smoked marijuana in humans. Psychopharmakology 1999; 141: 395–404

    Article  CAS  Google Scholar 

  • Hatch EE, Bracken MB: Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 1986; 124: 986–993

    CAS  PubMed  Google Scholar 

  • Heath RG, Fitzjarell AT, Fiontana CJ, Garey RE: Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. Biol Psychiatry 1980; 15: 657–690

    CAS  PubMed  Google Scholar 

  • Hepler RS, Frank IM: Marihuana smoking and intraocular pressure. J Am Med Assoc 1971; 217: 1392–1394

    Article  CAS  Google Scholar 

  • Hirst RA, Lambert DG, Notgutt WG: Pharmacology and potential therapeutic uses of cannabis. B J Anaest 1998; 81: 77–84

    CAS  Google Scholar 

  • Hollister LE: Cannabis 1988. Acta Psychiatr Scand 1988; 78: 108–118

    Google Scholar 

  • Jain AK, Ryan JR, McMahon FG, Smith G: Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol 1981; 21: 320–326

    Google Scholar 

  • Janse AFC, Breekveldt-Postma NS, Erkens JA: Medicinal cannabis in the Netherlands. PHARMO Institute for Drug Outcomes Research 2004

    Google Scholar 

  • Johannson R, Kikku P, Groenroos M: A double blind controlled trial of Nabilone vs prochlorperazin for refactory emesis induced by cancer chemotherapy. Canc Treat Rev 1982; 9: 25–33

    Article  Google Scholar 

  • Johnston LD, O’Malley PM, Bachmann JG: National survey results on drug use, 1975–1994 (Vol. 1). Washington DC: US Department of Health ans Human Services 1995

    Google Scholar 

  • Jones RT: Cannabis tolerance and dependence. In: Fehr KO, Kalant H (Eds.). Cannabis and health hazards. Toronto Addiction Research Foundation 1983

    Google Scholar 

  • Kelly TH, Foltin RW, Emurian CS, Fischman MW: Performancebased testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol and diazepam. J Anal Toxicol 1993; 17: 264–272

    CAS  PubMed  Google Scholar 

  • Kozer E, Koren G: Effects of prenatal exposure to marijuana, Can Fam Physician 2001; 47: 263–264

    CAS  PubMed  Google Scholar 

  • Kuczkowski KM: Marijuane in pregnancy. Ann Academy Med 2004; 33: 336–339

    CAS  Google Scholar 

  • Kuitjen RR, Bunin GR, Nass CC, Meadows AT: Parental occupation and childhood astrocytoma. Cancer Res 1992; 52: 782–786

    Google Scholar 

  • Kumar RN, Chambers WA, Pertwee RG: Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesth 2001; 56: 1059–1068

    Article  CAS  Google Scholar 

  • Lawson TM, Rees A: Stroke and transient ischaemic attacks in association with substance abuse in young man. Postgrad Med 1996; 72: 692–693

    Article  CAS  Google Scholar 

  • Ledent C, Valverde O, Cossu G et al.: Unresponsivness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999; 283: 401–404

    Article  CAS  PubMed  Google Scholar 

  • Leirer VO, Yesavage JA, Morrow DG: Marijuana carryover effects on aircraft pilot performance. Aviat Space Environ Med 1991; 62: 221–227

    CAS  PubMed  Google Scholar 

  • Lindstrom P, Lindblom U, Boreus L: Lack of effect of cannabidiol in sustained neuropathia. Paper presented at Marijuana International Conference of Cannabis, Melbourne 1987

    Google Scholar 

  • Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, Nelson EC: Escalation of drug use in early-onset cannabis users vs co-twin controls. Jama 2003; 289: 427–433

    Article  PubMed  Google Scholar 

  • MacInnes DC, Miller KM: Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Practitioners 1984; 34: 575–576

    CAS  Google Scholar 

  • Mallat A: Preoperative marijuana inhalation — an airway concern. Can J Anaesth 1996; 43: 691–693

    Article  CAS  PubMed  Google Scholar 

  • Martyn CN, Illis LS, Thom J: Nabilone in the treatment of multiple sclerosis. Lancet 1995; 345: 579

    Article  CAS  PubMed  Google Scholar 

  • Maslov LN, Lasukova OV, Krylatov AV, Uzachenko RV, Pertwee R: Selectiv cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP. Bullentin of Experimental Biology and Medicine 2004; 138: 550–553

    Article  CAS  Google Scholar 

  • Mateo I, Pinedo A, Gomez-Belldarain M, Basterretxea JM, Garcia-Monco JC: Recurrent stroke associated with cannabis use: J Neurol Neurosurg Psychiatry 2005; 76:435–437

    Article  CAS  PubMed  Google Scholar 

  • Maykut MO: Health consequenences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9: 209–238

    Article  CAS  PubMed  Google Scholar 

  • Menezes PR, Johnson S, Thornicroft G: Drug and alcohol problems among individuals with severe mental illness in South-London. Br J Psychiatry 1996; 186: 612

    Article  Google Scholar 

  • Mills PM: Cannabis abuse and anaesthesia. Anaesth 2003; 58: 1119–1146

    Article  Google Scholar 

  • Musty RE, Reggio P, Sroe P: A review of recent advances in cannabinoid research and the 1994 international symposium on cannabis and the cannabinoids. Life Sci 1995; 56: 1933–1940

    Article  CAS  PubMed  Google Scholar 

  • Noyes R, Brunk SF, Baram DA, Baram A: The analgesic properties of delta-9-tetrahydrocannabinol. J Clin Pharmacol 1975; 15: 139–143

    PubMed  Google Scholar 

  • Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W: Cannabis use and mental health in young people — a cohort study. BMJ 2002; 325: 1195–1198

    Article  PubMed  Google Scholar 

  • Pertwee RG: Cannabinoid pharmacology: the first 66 years. B J Pharmacol 2006; 147: 163–171

    Article  CAS  Google Scholar 

  • Pope HG, Yurgelund-Todd D: The residual cognitive effects of heavy marijuana use in college students. JAMA 1996; 275: 521–527

    Article  CAS  PubMed  Google Scholar 

  • Raft D, Gregg J, Ghiaj Harris L: Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. Clinical Pharmacology and Therapeutics 1977; 21: 26–33

    CAS  PubMed  Google Scholar 

  • Robison LI, Buckley JD, Daigle AE: Maternal drug use and the risk of childhood nonlymphoblastic leukaemia among offspring: an epidemiologic investigation implicating marijuana. Cancer 1989; 63: 1904–1911

    CAS  PubMed  Google Scholar 

  • Seeling W, Kneer L, Bächele B et al.: Keine synergistische Wirkung der Kombination von Delta-9-Tetrahydrocannabinol und Piritramid bei postoperativen Schmerzen. Anaesthesist 2006; 55: 391–400

    Article  CAS  PubMed  Google Scholar 

  • Seeling W, Kneer L, Bächele B et al. Keine synergistische Wirkung der Kombination von δ9-Tetrahydrocannbaninol und Piritramid bei postoperativen Schmerzen. Pain 2003, 106: 169–172

    Article  CAS  Google Scholar 

  • Smith DE, Seymour RB: Cannabis and cannabis withdrawal. J Subst Misuse 1996; 2: 49–53

    Article  Google Scholar 

  • Smith NT: A review of the published literature into cannabis withdrawal syndrome in a large population. Addiction 2002; 97:621–632

    Article  PubMed  Google Scholar 

  • Solowij N, Stephens RS, Roffmann RA, Babor T, Kadden R, Miller M: Cognitiv functioning of long term heavy cannabis users seeking treatment. Jama 2002; 287: 1123–1131

    Article  PubMed  Google Scholar 

  • Sragg RK, Mitchell EA, Ford RP, Thompson JM, Taylor BJ, Steward AW: Maternal cannabis use in the sudden death syndrome. Acta Paediatr 2001; 90: 57–60

    Article  Google Scholar 

  • Symons IE: Cannabis smoking and Anaesthesia. Anaesth 2002; 57: 1134–1145

    Article  Google Scholar 

  • Tanda G, Pantieri FE, Di Chiara G: Cannabinoide and heroin activation of mesolimbic dopamin transmission by a commen M1 opioid receptor mechanism. Science 1997; 276: 2048–2078

    Article  CAS  PubMed  Google Scholar 

  • Tashkin D: Cannabis. Ann Intern Med 1978; 89: 539–549

    CAS  Google Scholar 

  • Tennant FS, Preble M, Dergast TJ, Ventry P: Medical manifestations associated with hashish. JAMA 1971; 216: 1965–1969

    Article  PubMed  Google Scholar 

  • Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM: Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neurosci 1998; 83: 393–411

    Article  CAS  Google Scholar 

  • Wickelgren I: Marijuana: Harder than thought? Science 1997; 276: 1967–1970

    Article  CAS  PubMed  Google Scholar 

  • White SM: Cannabis abuse and laryngospasm. Anaesth 2002; 57: 606–625

    Article  Google Scholar 

  • Wu TC, Tashkin DP, Djahed B, Rose JE: Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318: 347–351

    Article  CAS  PubMed  Google Scholar 

  • Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G: Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1195–1198

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universität Rostock, Schillingallee 35, 18057, Rostock

    Dr. C. E. Beck

Authors
  1. Dr. C. E. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universität Rostock, Schillingallee 35, 18057, Rostock

    Dierk A. Vagts DEAA, EDIC (MSc. Krankenhausmanagement Oberarzt, Leiter der Perioperativen Intensivtherapie (PIT) (MSc. Krankenhausmanagement Oberarzt, Leiter der Perioperativen Intensivtherapie (PIT)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Beck, C.E. (2007). Cannabis. In: Vagts, D.A. (eds) Suchtmittel in der AINS. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33734-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33734-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33733-1

  • Online ISBN: 978-3-540-33734-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation